Technical Analysis for VPRO - Viropro Inc

Grade Last Price % Change Price Change
grade D 0.0008 0.00% 0.0000
VPRO closed unchanged on Thursday, December 5, 2019, on 55 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
See historical VPRO trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Bands Range Expansion 0.00%
Older signals for VPRO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases, such as cancer, diabetes, hepatitis, or multiple sclerosis. It manufactures biologics drugs, including bio-similars for pre-clinical, and Phase I, II, and III clinical trials; offers its clients with supply of mammalian cell proteins, such as monoclonal antibodies or recombinant proteins, or other cell-derived products; owns three clones that include two in insulin therapy and one for cancer therapy; and provides contractual research and manufacturing services to biotech and biopharmaceutical companies. The company's contractual work activities include cloning, sequencing, purifying, developing, validating, and producing biopharmaceutical products and sub-products. It has operations in Canada, the United Kingdom, and Malaysia. Viropro Inc. has collaboration agreement with Oncobiologics, Inc. to manufacture and commercialize monoclonal antibody products. The company is based in San Jose, California. Viropro Inc. is a subsidiary of Alpha Biologics Limited.
Biotechnology Cancer Biopharmaceutical Life Sciences Biology Diabetes Diseases Antibodies Multiple Sclerosis Hepatitis Cloning Monoclonal Antibody Biopharmaceutical Products Cancer Therapy Manufacturing Services Treating Cancer Recombinant Dna Biosimilar Treatment Of Various Diseases Biogen Pharming

Is VPRO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.01
52 Week Low 0.0003
Average Volume 144,366
200-Day Moving Average 0.0019
50-Day Moving Average 0.0010
20-Day Moving Average 0.0007
10-Day Moving Average 0.0006
Average True Range 0.0007
ADX 12.92
+DI 32.2034
-DI 28.8136
Chandelier Exit (Long, 3 ATRs ) -0.0009
Chandelier Exit (Short, 3 ATRs ) 0.0024
Upper Bollinger Band 0.0012
Lower Bollinger Band 0.0002
Percent B (%b) 0.6
BandWidth 142.8571
MACD Line -0.0003
MACD Signal Line -0.0001
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0016
Resistance 3 (R3) 0.0015 0.0011 0.0014
Resistance 2 (R2) 0.0011 0.0009 0.0012 0.0014
Resistance 1 (R1) 0.0010 0.0008 0.0011 0.0011 0.0013
Pivot Point 0.0006 0.0006 0.0007 0.0007 0.0006
Support 1 (S1) 0.0005 0.0004 0.0006 0.0006 0.0003
Support 2 (S2) 0.0001 0.0003 0.0002 0.0002
Support 3 (S3) 0.0000 0.0001 0.0002
Support 4 (S4) 0.0001